Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
- PMID: 10922410
- DOI: 10.1093/jnci/92.15.1252
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
Abstract
Background: Studies by comparative genomic hybridization (CGH) have shown that chromosomal region 17q23 is amplified in up to 20% of primary breast cancers. We used microarray analyses to measure the expression levels of genes in this region and to explore their prognostic importance.
Methods: A microarray that contained 4209 complementary DNA (cDNA) clones was used to identify genes that are overexpressed in the MCF-7 breast cancer cell line as compared with normal mammary tissue. Fluorescence in situ hybridization was used to analyze the copy number of one overexpressed gene, ribosomal protein S6 kinase (S6K), and to localize it to the 17q23 region. Northern and western blot analyses were used to measure S6K gene and protein expression, and an enzymatic assay was used to measure S6K activity. Tumor tissue microarray analysis was used to study amplification of S6K and the HER-2 oncogene, another 17q-linked gene, and the relationship between amplification and prognosis was analyzed. The Kaplan-Meier method was used for data analysis, and the log-rank test was used for statistical analysis. All P values are two-sided.
Results: S6K was amplified and highly overexpressed in MCF-7 cells relative to normal mammary epithelium, and protein expression and enzyme activity were increased. S6K was amplified in 59 (8.8%) of 668 primary breast tumors, and a statistically significant association between amplification and poor prognosis (P =.0021) was observed. Amplification of both S6K and HER-2 implied particularly poor survival (P =.0001).
Conclusions: The combination of CGH information with cDNA and tissue microarray analyses can be used to identify amplified and overexpressed genes and to evaluate the clinical implications of such genes and genomic rearrangements. S6K is likely to be one of the genes at 17q23 that is amplified during oncogenesis and may adversely affect the prognosis of patients with this amplification.
Similar articles
-
Multiple genes at 17q23 undergo amplification and overexpression in breast cancer.Cancer Res. 2000 Oct 1;60(19):5340-4. Cancer Res. 2000. PMID: 11034067
-
Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions.Genes Chromosomes Cancer. 1997 Dec;20(4):372-6. doi: 10.1002/(sici)1098-2264(199712)20:4<372::aid-gcc8>3.0.co;2-z. Genes Chromosomes Cancer. 1997. PMID: 9408753
-
New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.Cancer Res. 2001 Nov 15;61(22):8235-40. Cancer Res. 2001. PMID: 11719455
-
[HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].Ann Pathol. 2011 Dec;31(6):472-9. doi: 10.1016/j.annpat.2011.10.013. Epub 2011 Nov 26. Ann Pathol. 2011. PMID: 22172120 Review. French.
-
The 17q23 amplicon and breast cancer.Breast Cancer Res Treat. 2003 Apr;78(3):313-22. doi: 10.1023/a:1023081624133. Breast Cancer Res Treat. 2003. PMID: 12755490 Review.
Cited by
-
Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoforms.PLoS One. 2012;7(10):e48745. doi: 10.1371/journal.pone.0048745. Epub 2012 Oct 31. PLoS One. 2012. PMID: 23119097 Free PMC article.
-
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.J Clin Pathol. 2007 May;60(5):534-9. doi: 10.1136/jcp.2006.039552. Epub 2006 Jun 30. J Clin Pathol. 2007. PMID: 16816167 Free PMC article.
-
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms.Cell Oncol (Dordr). 2020 Jun;43(3):421-430. doi: 10.1007/s13402-020-00496-7. Epub 2020 Mar 5. Cell Oncol (Dordr). 2020. PMID: 32141029 Free PMC article.
-
BCAS3 exhibits oncogenic properties by promoting CRL4A-mediated ubiquitination of p53 in breast cancer.Cell Prolif. 2021 Aug;54(8):e13088. doi: 10.1111/cpr.13088. Epub 2021 Jul 9. Cell Prolif. 2021. PMID: 34240781 Free PMC article.
-
The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.Oncologist. 2013;18(5):493-500. doi: 10.1634/theoncologist.2012-0419. Epub 2013 May 1. Oncologist. 2013. PMID: 23635555 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous